Table 1. Baseline characteristics of patients with KD and control patients.
| Parameters | KD (n = 46) | Febrile control (n = 23) | Afebrile control (n = 10) | P |
|---|---|---|---|---|
| Age, mon | 33.78 ± 21.95 | 37.17 ± 19.79 | 30.00 ± 17.81 | 0.643 |
| Gender (male/female) | 26/20 | 12/11 | 5/5 | 0.813 |
| Weight, kg | 13.94 ± 4.10 | 14.29 ± 4.09 | 13.66 ± 5.52 | 0.916 |
| BMI, kg/m2 | 16.51 ± 2.12 | 15.96 ± 1.50 | 16.63 ± 1.87 | 0.483 |
| Hemoglobin, g/dL | 11.58 ± 0.82 | 11.64 ± 1.21 | 12.47± 0.50 | 0.034 |
| WBC, 103/µL | 13.44 ± 4.24 | 8.58 ± 3.83 | 8.59 ± 2.85 | < 0.001 |
| Platelet count, 104/µL | 33.80 ± 11.84 | 22.80 ± 11.87 | 39.09 ± 16.82 | 0.088 |
| Neutrophil, % | 66.40 ± 12.95 | 49.57 ± 17.22 | 43.41 ± 20.23 | < 0.001 |
| Albumin, g/dL | 4.09 ± 0.26 | 4.10 ± 0.19 | 4.29 ± 0.16 | 0.066 |
| AST, U/L | 97.35 ± 136.06 | 43.52 ± 20.08 | 44.50 ± 18.99 | 0.091 |
| ALT, U/L | 102.91 ± 188.05 | 22.09 ± 21.28 | 22.50 ± 8.39 | 0.057 |
| ESR, mm/hr | 46.96 ± 27.18 | 24.15 ± 19.82 | 8.86 ± 5.84 | < 0.001 |
| CRP, mg/dL | 5.31 ± 3.59 | 1.74 ± 1.56 | 0.07 ± 0.02 | < 0.001 |
| NT-proBNP, pg/mL | 1,031.34 ± 1,152.60 | 136.94 ± 96.99 | 59.43 ± 36.71 | < 0.001 |
| Procalcitonin, ng/mL | 1.02 ± 2.06 | 0.46 ± 0.70 | 0.14 ± 0.04 | 0.662 |
| Total cholesterol, mg/dL | 134.57 ± 23.54 | 141.29 ± 24.05 | 142.67 ± 37.09 | 0.566 |
| HDL-C, mg/dL | 31.72 ± 8.81 | 33.36 ± 6.70 | 37.33 ± 12.61 | 0.323 |
| PDMP, nmol | 12.04 ± 5.58 | 9.27 ± 5.91 | 8.18 ± 2.88 | 0.059 |
KD = Kawasaki disease, BMI = body mass index, WBC = white blood cell, AST = aspartate aminotransferase, ALT = alanine aminotransferase, ESR = erythrocyte sedimentation rate, CRP = C-reactive protein, NT-proBNP = N-terminal pro-brain natriuretic peptide, HDL-C = high-density lipoprotein-cholesterol, PDMP = platelet-derived microparticle.